Applied DNA Promotes Judith Murrah to Chief Operating Officer

Author's Avatar
Jan 20, 2021
Article's Main Image

Applied+DNA+Sciences%2C+Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the promotion of Chief Information Officer Judith Murrah to the role of Chief Operating Officer effective immediately. The promotion formalizes Ms. Murrah’s expanding range of responsibilities that includes the development of key customer and partner relationships, QA oversight, and operations management. Ms. Murrah has been instrumental in the undertaking of capacity expansions for pooled COVID-19 surveillance testing at the Company’s wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC, and for the ongoing implementation of Current Good Manufacturing Practices (“cGMP”) at LineaRx, a majority-owned subsidiary of the Company. The Company believes that the implementation of cGMP at LineaRx is necessary to respond to opportunities in nucleic acid-based therapeutics – drugs and biologics – via the Company’s large-scale, PCR-based LinearDNA™ platform.